The Altered Pharmaceutical Thought Leader Pool: How the Implementation of the Sunshine Act and CMS Open Payment Program Changed the KOL Landscape
Since the adoption of the Sunshine Act in 2010 and the subsequent thought leaders’ payments reporting on the CMS Open Payment Program in 2014, many things have changed for pharmaceutical companies.
It took a fairly short time for pharmaceutical organizations to adapt to the disruptions that the Physician Payment Sunshine Act and healthcare reform presented. Though affected the most by these changes, it appears that Medical Affairs operations, including Medical Science Liaison (MSL) teams, have now realigned to the new realities.
From this realignment stemmed new functions, such as Thought Leader Development, and the expansion of regulatory and compliance’s role in how Medical Affairs and MSLs interact with Thought Leaders and physician communities.
The new rules seemed to a